Newlife to develop wristwatch heart rate monitor:
This article was originally published in Clinica
US company Newlife Technologies is to use technology licensed from BTG International to develop a wristwatch-like device that can noninvasively monitor vital signs in the human body, such as heart rate. The technology consists of an optical fibre sensor that can pick up physiological changes in the body through the strap, Steve Burton, Newlife's president told Clinica. The Midlothian, Virginia-based company will use the technology to enhance its FDA-approved heart rate monitoring product, the HEARTalker, which vocally feeds back ECG measurements from a strap worn around the chest to assist the user during personal training.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.